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840 Adult Congenital Heart Disease
Tuesday, March 09, 2004, 10:30 a.m.-Noon
Morial Convention Center, Room 260
10:30 a.m.
840-1 Myocardial Fibrosis Patterns Correlate With Adverse 
Right Ventricular Morphology and Function in Patients 
With Repaired Conotruncal Heart Defects
Anne Marie Valente, Salim F. Idriss, Peter Cawley, John Heitner, Igor Klem, Jospeh Kay, 
Ann Marie Nawrocki, Michele Parker, J. Rene' Herlong, Raymond Kim, Duke University 
Medical Center, Durham, NC
Background: Repair of tetralogy of Fallot (TOF) and transposition of the great arteries
(TGA), the most common conotruncal congenital heart defects, often results in right ven-
tricular (RV) volume and/or pressure overload. RV failure often ensues over time. Myo-
cardial fibrosis may be an important correlate of RV dysfunction and adverse RV
remodeling. Delayed contrast enhancement cardiac MRI (DEMRI) is known to be a sen-
sitive technique for determining the presence, location and extent of myocardial fibrosis
in vivo. The purpose of this study was to correlate the presence, location and extent of
myocardial fibrosis on DEMRI with RV volumes and function, as well as QRS duration in
patients with repaired TOF or TGA.
Methods: Twenty seven patients with TOF or TGA were prospectively identified and
underwent cine and DEMRI. Measurements of RV morphology and function were
assessed on the cine images, and the extent of hyperenhancement (HE) was assessed
on delayed enhancement images. QRS duration was measured from the standard elec-
trocardiogram.
Results: All patients, regardless of RV size and function, had evidence of some myocar-
dial fibrosis as determined by the presence of HE. However, there was a predilection of
myocardial fibrosis for specific locations. In particular, the junction of the RV freewall with
the interventricular septum was commonly involved (100% at the inferior septal junction,
56% at the anterior septal junction). Six patients (22%) had direct involvement of the right
ventricular free wall. The extent of HE correlated with RVEDV and RVESV (p<0.01). In
addition, QRS duration correlated with RVEDV, RVESV, and RVEF (p<0.05, all).
Conclusion: Patients with repaired conotruncal congenital heart defects such as TOF and
TGA have areas of myocardial fibrosis that are located remote from sites of direct surgi-
cal intervention. The concentration of myocardial fibrosis in these unexpected locations
remains to be explained. The extent of fibrosis in these patients and QRS duration corre-
lates with adverse right ventricular morphology and function. Future investigations of the
relationship between right ventricular fibrosis characteristics and outcomes in this patient
population are necessary.
10:45 a.m.
840-2 Mismatch of the Coronary Circulation: Impact on the 
Systemic Right Ventricle
Michael Hauser, Heiko Stern, Frank Bengel, Sohrab Fratz, Alfred Hager, Stefan Nekolla, 
Harald Kaemmerer, Markus Schwaiger, John Hess, German Heart Centre Munich, 
Munich, Germany, Nuklearmedizinische Klinik der TU-Munich, Munich, Germany
Background: Ventricular dysfunction of the systemic right ventricle (RV) is evident in at
least 10% of patients at 10 years and may be caused by a mismatch between O2
demand and supply.
Methods: We investigated 20 patients (22.7 SD 4.9 yrs) with TGA after atrial repair (ASO)
and 15 patients (30.6 SD 16.4 yrs) with unoperated congenitally corrected transposition
(CCTGA); 11 normals (26.2 SD 5.2 yrs) served as controls for the myocardial blood flow
(MBF). All patients had spiroergometry, MRI and positron emission tomography (NH3,
rest / Adenosine); all ASO patients additionally had cardiac catherization.
Results: MBFrest did not differ between patients with ASO, CCTGA and controls, whilst
MBFstress (ASO 167 SD 46* vs. CCTGA 198 SD 38* vs. controls 310 SD 74 ml/100g/
min.; p<0.001) and coronary flow reserve (ASO 2.3 SD 0.4* vs. CCTGA 2.6 SD 0.6* vs.
controls 4.1 SD 0.7; p<0.001) were significantly reduced; angiography did not show any
stenosis of the coronary arteries, suggesting microvascular disease. In both patient
groups a negativ correlation between ventricular mass and MBFrest could be calculated.
In CCTGA there additionally was a significant correlation between CFR and the increase
of the systolic function after dobutamine administration on MRI (r=0.71; p<0.01), BNP-
levels (r=0.69; p<0.01) and VO2 max. (r=0.62; p<0.01). In patients with ASO, CFR is not
significantly correlated with ventricular function, BNP and VO2 max, suggesting a multi-
factorial process (attenuated atrial compliance with reduced preload).
Conclusion: The intrinsic geometry of the systemic RV and the process of remodelling
(myocyte hypertrophy and disarray, interstitial fibrosis, inadequate capillary growth, thick-
ening of the media of intramural coronary arteries) may contribute to limited nutritional
support with ventricular deterioration and electrical instability; the mismatch between O2
demand and supply is an important risk factor for the long-term prognosis of patients with
morphologic right ventricle; in patients with TGA after atrial repair it is at least one impor-
tant cofactor causing ventricular deterioration.
11:00 a.m.
840-3 Bicuspid Aortic Valve in Athletes: An Underestimated 
Problem?
Giorgio Galanti, Marta Rizzo, Paolo Manetti, Valentina Di Tante, Alfredo Guerrisi, Maria 
Concetta Robertina Vono, Jacopo Giuliattini, Loira Toncelli, University of Florence, 
Florence, Italy
Background. Bicuspid aortic valve (BAV) is likely to be a common cardiac disease in ath-
letes, however to date, limited data are available. The great concern of sports medicine
physicians for BAV is related to the valvular and vascular complications characterizing
the natural history of disease which are likely to be accelerated or worsen by athletic
training.
Object. The present investigation was designed to evaluate the prevalence of bicuspid
aortic valve (BAV) among a large group of unselected, competitive asymptomatic ath-
letes and the prevalence and the extent of associated complications, compared to those
reported in community-based studies.
Method. In a 3-years period, 2273 (788 F and 1485 M) consecutive competitive athletes
aged 8 to 60 years (average: 31±11.3 years), representing 16 different sports were eval-
uated by Echocardiography (Echo). Echo measurements included aortic root dimensions
at four levels: aortic annulus, sinuses of Valsalva, sinotubular junction and proximal
ascending aorta.
Results. BAV was diagnosed in 58 athletes, corresponding to a prevalence of 2,55%, sig-
nificantly greater than prevalence reported in population-based studies.
BAV was normally functioning in only 9 athletes. Aortic regurgitation was detected in the
other 49 athletes. It was mild in 14 athletes, moderate in 27 and moderate-to-severe in 8.
A moderate aortic stenosis was documented in two athletes.
Aortic root dimensions at all the measured levels were significantly larger in athletes with
BAV than in athletes with tricuspid aortic valve. Aortic dilatation was not associated with
age, body surface area, presence and extent of aortic regurgitation, nor with the years of
training.
15 BAV athletes were disqualified from competition because severe aortic regurgitation
associated to left ventricular dilatation or aortic dilatation, independently from valvular
functioning.
Conclusions. The results of this investigation highlights on the high prevalence of BAV
and its complications in athletic population and suggest the importance of strongly sup-
port the implementation of pre-participation screening with echocardiography
11:15 a.m.
840-4 Failing Fontan Circulation Necessitating 
Transplantation: A Clinicopathologic Correlation
Fotios A. Mitropoulos, Hillel Laks, Jacques Neelankavil, Juan Alejos, John S. Child, Vivek 
Allada, Stacey Drant, Jon Kobashigawa, Jonah Odim, Michael Fishbein, Mark Plunkett, 
UCLA Medical Center, Los Angeles, CA, Mattel's Childrens Hospital, Los Angeles, CA
Background: Some patients with Fontan palliation for univentricular congenital heart dis-
ease will eventually fail and require orthotopic heart transplantation (OHT).This particular
mode of cardiovascular failure has been investigated in the past focusing primarily on the
Fontan pathway and its obstruction. We sought to describe and define the clinical-patho-
logic events that occur in the univentricular heart.
Methods: We retrospectively analyzed the data from 31 patients (19 males and 12
females) with Fontan physiology who underwent OHT at a mean age of 17 years (range,
7-48) with special emphasis on the pathological changes of the explanted heart.
Results: All 31 patients were in NYHA class III or IV, and 14/31 required pacemaker ther-
apy for arrhythmias (10/14 atrial dysrhythmias, 1/14 junctional bradycardia, 2/14 ventricu-
lar tachycardia, and 1/14 sick sinus syndrome). The mean Fontan pressure was 24.5
mmHg (range, 7-26). Echo data available in 24/31 revealed a mean ejection fraction of
23% (range, 10-45). In 19/24 patients atrioventricular valve regurgitation was moderate to
severe in 11/19 and mild in 7/19. Mean heart weight was 371g (range, 120-880). The
mean percentage of hypertrophy based on the patient’s height was 156% (range, 60-
436). Microscopically, fibrosis was present in all but one explanted heart: 10/31 had inter-
stitial fibrosis, 13/31 had replacement fibrosis, 7/31 had both, and 1/31 had myocardial
fibroelastosis. The mean free ventricular wall thickness was 1.75 cm (range, 1.0-3.2).
Conclusion: Failing univentricular hearts with Fontan circulation demonstrate similar clini-
copathologic changes to the biventricular hearts that fail. These findings argue for routine
anticongestive medical therapy post-Fontan to delay and/or prevent adverse remodeling
and failure of the univentricular heart. A prospective trial is proposed to address this
issue.
11:30 a.m.
840-5 Should Mechanical Valves Be Used in the Pulmonary 
Position
John M. Stulak, Heidi M. Connolly, Francisco J. Puga, Joseph A. Dearani, Carole A. 
Warnes, Hartzell V. Schaff, Mayo Clinic, Rochester, MN
Objectives: Bioprostheses are the most commonly used valve substitutes in the pulmo-
nary position, but most require late re-replacement. Mechanical valves may have better
durability, but there are conflicting reports regarding late outcome of these prostheses for
pulmonary valve replacement (PVR).
Methods: We reviewed 10 patients (pts) (27 +/- 12 years (yrs)) who underwent mechani-
cal PVR between January 1969 and June 2002. Diagnoses included carcinoid heart dis-
ease (n=4), double outlet right ventricle (n=2), pulmonary stenosis/atresia (n=2),
transposition of the great arteries (n=1), and truncus arteriosus (n=1). Eight had PVR at
our institution and 2 pts underwent PVR elsewhere.
JACC March 3, 2004 ABSTRACTS - Pediatric Cardiology and Adult Congenital Heart Disease  391A
Pediatric Cardiology and Adult Congenital Heart Disease
Results: Indications for PVR were valvular regurgitation (n=6), obstruction (n=3), and
both (n=1). Valve types were St. Jude (n=7), Starr-Edwards (n=2), and Bjork-Shiley
(n=1). In 5 pts, the mechanical PVR was placed within a conduit. Concomitant mechani-
cal tricuspid valve replacement (St. Jude) was performed in 6 pts. Postoperatively, all but
1 were anticoagulated with warfarin. During late follow-up (8.3 +/- 7.7 yrs, max 25 yrs), 1
pt required repeat PVR for outgrowth of prosthesis 25 yrs postoperatively, and 1 pt with
normal prosthetic pulmonary valve function underwent heart transplantation for severe
biventricular failure 3.5 yrs postoperatively. The average mean gradient across the
mechanical PVR by echocardiography in the remaining 8 pts was 11 +/- 7 mmHg. There
were no perivalvular leaks or vegetations, and no evidence of pannus formation or pros-
thesis dysfunction. There were 3 late minor bleeding events (epistaxis in 2 pts and men-
orrhagia in 1). There was 1 sudden late death 15 yrs after PVR, and 1 death from
unknown causes in the aforementioned pt with outgrowth of the mechanical PVR, 5.5 yrs
post re-PVR with a bioprosthesis. There were no cases of pulmonary emboli or PVR
thrombosis.
Conclusions: Mechanical PVR appears to provide excellent durability and hemodynamic
results without mechanical valve failure or valve thrombosis in this small series. Mechan-
ical prostheses should be considered for PVR in selected pts, particularly those who
require chronic warfarin anticoagulation for other reasons.
11:45 a.m.
840-6 Coarctation Long-Term Assessment (COALA-Study) 
Incidence of Restenosis and Hypertension After 
Surgical Repair
Alfred Hager, Simone Kanz, Harald Kaemmerer, Christian Schreiber, John Hess, 
Deutsches Herzzentrim München, TUM, München, Germany
Background: to assess the incidence of restenosis and arterial hypertension in patients
after surgical repair of aortic coarctation in a cross sectional study.
Patients and Methods: From 1974 to now 405 patients born before 1.1.1965 underwent
surgery for isolated aortic coarctation in our hospital. From those 383 who are still alive
26 moved to remote or unknown areas and 83 denied a follow up examination at our
institution. The study group of the remaining 274 patients (16 - 73 years old, 90 female,
184 male, 72% of those that are still alive), 18.4 ± 5.9 years (range 1 - 27 years) after sur-
gery, underwent a structured clinical investigation with a Doppler sonographic measure-
ment of the blood pressure at all limbs, exercise test, and ambulatory blood pressure
measurement.
Results: 29 patients (11%) already underwent surgery for restenosis, another 20 patients
(7%) had a leg-arm gradient of more than 20 mmHg suggesting restenosis now. Risk fac-
tors were young age at the first repair and first repair without end-to-end anastomosis.
67 Patients (24%) were already on antihypertensive drug therapy, another 48 patients
(18%) had a mean systolic blood pressure of 134 mmHg or higher in ambulatory blood
pressure measurement and should therefore also be classified hypertensive. Further-
more, another 28 patients (10%) showed a blood pressure during exercise exceeding 2
SD of reference values. All in all, only 131 patients (48%) had a normal blood pressure
reaction. The only independent risk factors for an abnormal blood pressure was a repair
without end-to-end anastomosis. Other risk factors like age at repair, age at investigation,
and body weight at investigation were not significant in a multiple regression analysis
anymore.
Conclusions: In the long-term follow up 18% of patients after surgery for aortic coarcta-
tion show restenosis. An arterial hypertensive blood pressure reaction is much more
common in long term follow up with an incidence of 52%. In only few patients hyperten-
sion is due to restenosis. Best results were achieved in patients in whom an end-to-end
anastomosis could be performed and in whom repair was not performed at a very young
age.
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1152-199 Thromboembolic Events Among Children With 
Cardiomyopathy: Results From the National Australian 
Childhood Cardiomyopathy Study
Robert G. Weintraub, Patty Chondros, Alan Nugent, John Carlin, Piers E.F Daubeney, 
National Australian Childhood Cardiomyopathy Study, Melbourne, Australia
Background: Subjects with cardiomyopathy (CM) are at risk from thromboembolism.
There is little information about predisposing factors and the magnitude of the risk in chil-
dren.
Methods: The National Australian Childhood Cardiomyopathy Study is a population-
based study, including all children in Australia with primary CM who presented at 0-10
years of age. Cases were classified according to WHO criteria. A thromboembolic event
was defined as the finding of intracardiac thrombus, or onset of organ dysfunction related
to an embolic event. Risk factors examined included CM type, congestive heart failure
(CHF) at diagnosis, duration of inotropic therapy, mechanical ventilation, ICU and hospi-
tal stay at presentation. Children not surviving 24 hours from presentation were excluded
from survival analysis. Study end-points were death or transplantation.
Results: There were 314 patients diagnosed with CM during the study period, of which
299 were included in survival analysis. Of these, 19 (6.4%) of these developed throm-
boembolic complications, including 14/172 (8.1%) with dilated CM, 3/39 (7.7%) with
unclassified CM, 1/12 (8.5%) with restrictive CM and 1/80 (1.2%) with hypertrophic CM
(p=0.02 compared to other cases). 6 of 19 (31.6%) of thromboembolic events occurred
<2 days of presentation and 14 (73.7%) occurred <30 days. CHF at presentation was
related to risk of thromboembolism (hazard ratio 5.0; 95% CI: 1.6-21.8). The one and 5-
year survival free from thromboembolic events were 93% (95% CI: 89-96%) and 91%
(95% CI 84-95%), respectively, for children with dilated CM, and 92% (95% CI: 76-97%)
at both time points for children with unclassified CM. Embolic phenomena included a
cerebrovascular event in 5 cases and a pulmonary embolus in 1. The risk of death or
transplantation was significantly increased for all study patients with thromboembolism
(hazard ratio 4.2; 95%CI: 1.6-11.2) as well as for those with dilated CM alone (hazard
ratio 4.6; 95% CI: 1.45-14.6).
Conclusions: Thromboembolism occurs in up to 9% of children with CM within one year
of diagnosis and is related to early CHF and CM type. Thromboembolic complications
occur early and are associated with an increased risk of death or transplantation.
1152-200 N-Terminal Pro-B-Type Natriuretic Peptide Differentiates 
Lung From Heart Disease in Infants With Respiratory 
Distress
Shlomo Cohen, Chaim Springer, Zeev Perles, Azaria JJT Rein, Avraham Avital, Zvi 
Argaman, Amiram Nir, Hadassah University Hospital, Jerusalem, Israel, Shaarei Zedek 
Medical Center, Jerusalem, Israel
Background: Respiratory distress (RD) is a common symptom in infants. RD is usually
caused by lung disease, but can also be a result heart disease. It is often difficult do
determine the cause of RD. N-terminal pro-B-type natriuretic peptide (N-BNP) is co-
secreted along with BNP from cardiac myocytes. Like BNP, N-BNP is a marker for car-
diac volume and pressure overload.
Aim: To determine whether N-BNP levels can differentiate between lung disease and
heart disease in infant with RD.
Methods: Infants (age 1-36m) who presented at Hadassah University Hospital with RD
underwent physical examination, chest X-ray, arterial blood gases and echocardiogram.
Control N-BNP values were obtained from age-matched babies with no acute illness and
no history or signs for heart or lung disease. Plasma N-BNP levels were measured by
Electrochemiluminescence immunoassay (Roche, Germany).
Results: There were 18 infants with lung disease (laryngitis, pneumonia and RSV bron-
chiolitis), 19 infants with heart disease (myocarditis, dilated cardiomyopathy, atrio-ventric-
ular canal, hypertrophic cardiomyopathy and ventricular septal defect) and 16 healthy
infants. Infants with respiratory distress due to heart disease had significantly higher
plasma N-BNP than infants with respiratory distress due to lung disease or control
(table).
* p<0.001 vs lung and vs control; # p<0.05 vs control.
Conclusions: Plasma N-BNP can differentiate infants with RD due to heart disease form
infant with RD due to lung disease.
1152-201 Brain Natriuretic Peptide Correlates With Myocardial 
Performance Index in Congenital Heart Disease Patients
Alice A. Perlowski, John S. Child, Robert S. Ross, Pamela D. Miner, David Geffen School 
of Medicine-UCLA Medical Center, Los Angeles, CA
Background: The myocardial performance index (MPI) is an echocardiographic Dop-
pler-derived measure of ventricular function that has been previously validated in con-
genital heart disease(CHD) patients. It may be preferred over conventional non-invasive
measures of ventricular function in patients with complex anatomy, since it is neither
dependent on geometric shape nor heart rate. Although Brain Natriuretic Peptide (BNP)
is well described as a predictor of systolic and diastolic dysfunction in anatomically cor-
rect hearts, it is unclear how it relates to MPI in those with CHD.
Methods: We prospectively evaluated 54 adult patients with a broad range of both cyan-
otic and noncyanotic heart disease. Included were both surgically repaired and unre-
paired pts. Levels of BNP were measured in all subjects using standardized assays.
Doppler echocardiography was performed on the study subjects within six months of the
BNP assay. No subject had a change in functional clinical status during this interval.
Echo images were evaluated by an experienced observer blinded to BNP results and
clinical status. The MPI was calculated as the interval from AV valve closure to opening
minus ventricular ejection time, divided by ventricular ejection time. EF was calculated
with standard methodology by the same observer.
Results: Of a total of 54 patients with measurable left ventricular (LV) or univentricular
(UV) EFs, 34 had adequate data to calculate LV or UV MPIs. Of 30 pts with measurable
right ventricular (RV) EFs, 23 had adequate data to calculate RV MPIs. BNP was found to
be significantly correlated with LV/UV MPI (r= 0.461 with p= 0.006)and RV MPI (r= 0.748
with p < 0.0001) while LV/UV EF and RV EF had no significant correlation with BNP (r= -
0.189, p= 0.172; r= -0.066, p= 0.729, respectively) using a Pearson’s correlation coeffi-
cient test.
Conclusion: In patients with CHD, BNP correlates significantly with MPI but not with left,
right, or univentricular EF. This appears to be particularly true in the case of geometrically
Group Number Age-months
mean(±sd)
Respiratory rate
mean(±sd)
O2 saturation 
mean(±sd)
N-BNP (pg/ml) 
median
Control 16 14.3(5.4) 36(7.8) 97(1.4) 164
Lung 18 9.2(5.9) 62(16.1)# 89.4(3.7)# 311
Heart 19 11.9(12.3) 68(15.7)# 88.6(4.7)# 15403*
